EUROPEAN SOCIETY FOR RADIOTHERAPY AND ONCOLOGY

World Congress of Brachytherapy 2021

 

May 06-08, 2021 Online Congress
Close
N. Poster
Poster title
Applicant name
Status
  PP-117 HDR BT in Non melanoma Skin Cancer: Results and toxicity with different techniques and applicators. SILVIA RODRIGUEZ VILLALBA Received Received
  PP-118 Dosimeter evaluation for measurement of radial dose distributions for electronic brachytherapy Autumn Walter Received Received
  PP-119 8-Gy single-fraction HDR brachytherapy boost after WBI on localized breast cancer in young women ALONSO LA ROSA DE LOS RIOS Received Received
  PP-120 Applicator visualization using ultrashort echo time MRI for HDR endorectal brachytherapy Ellen Kerkhof Received Received
  PP-121 HDR Brachytherapy as Monotherapy for Prostate Cancer: Early Toxicity of a Randomized Phase II Trial Marjory Jolicoeur Received Received
  PP-141 Assessment of interstitial needles with 3D-TRUS in cervical cancer brachytherapy Johannes Knoth Received Received
  PP-142 Vaginal dose de-escalation in cervix brachytherapy GILLIAN ALDRED Received Received
  PP-143 Hybrid Tandem & Ovoids Brachytherapy in Locally Advanced Cervical Cancer:Dose & Tumor Volume Metrics Amanda Rivera Received Received
  PP-144 Intensity modulated HDR GYN cervix brachytherapy Justine Dupere Received Received
  PP-145 Catheter displacements and dosimetric impact in focal salvage high-dose-rate prostate brachytherapy. M.A. Moerland Received Received
  PP-146 Quality assurance of curved catheter paths in interstitial brachytherapy using a constructed phantom Nadin Abu-Hossin Received Received
  PP-147 Volumetric dosimetry for eye plaque brachytherapy using 3D treatment planning software Mohammad Rezaee Received Received
  PP-148 A brachytherapy process review and failure mode effect analysis during a system replacement. Emily Flower Received Received
  PP-149 Dosimetry of Intraocular Tumors with Small Apical Heights Using I-125 Plaques Mohammad Rezaee Received Received
  PP-150 Commissioning of a GPU-based multi-criteria optimisation algorithm for HDR brachytherapy Cédric Bélanger Received Received
  PP-151 A treatment analysis tool for clinical, dosimetric and outcome data reported in the EMBRACE trial Stefan Ecker Received Received
  PP-152 Proof of principle measurements for an intensity modulated brachytherapy tandem Marc Morcos Received Received
  PP-154 Knowledge-based Inverse Treatment Planning for Low-Dose-Rate Prostate Brachytherapy Christian Guthier Received Received
  PP-155 Antibiotic Prophylaxis for Prostate HDR Brachytherapy: Interim Results of a Phase III trial Marjory Jolicoeur Received Received
  PP-156 HDR and LDR comparison as monotherapy in localized prostate cancer: Late toxicity and PSA kinetic Thomas Reynaud Received Received
  PP-157 Long-term Outcomes of Prostate Cancer Patients treated with Low Dose Rate Brachytherapy Thomas McMullan Received Received
  PP-158 Registration accuracy of an integrated MR -TRUS navigation system for prostate HDR brachytherapy Samuel Kadoury Received Received
  PP-159 HDR Brachytherapy Monotherapy in patients with Low/Intermediate-risk Prostate Cancer ELENA MORENO-OLMEDO Received Received
  PP-160 Prostatitis after HDR brachytherapy monotherapy Marjory Jolicoeur Received Received
  PP-162 MR-assisted whole salvage HDR prostate brachytherapy with intra-prostatic boost: a prospective study Hans Chung Received Received
  PP-163 Very long-term biochemical and dosimetric outcomes of LDR boost in intermediate-risk prostate cancer Alai Gońi Ramirez Received Received
  PP-164 Focal Treatment of Prostate Cancer with 169Yb-based High Dose Rate Intensity Modulated Brachytherapy Josephine Lavoie Received Received
  PP-165 Contact X-Ray Brachytherapy for eyelid carcinoma: Efficacy and toxicity in 69 patients Shakeel Sumodhee Received Received
  PP-166 Failure modes and effects analysis guided implementation of 3D printed standoff for skin brachytherapy Kurt Byrnes Received Received
  PO-168 External beam radiotherapy and brachytherapy for partial breast irradiation: dosimetric comparison. Irina Akulova Received Received
  PO-169 Effects of uncertainty with Strut Adjusted Volume Implant applicator in Japan. Kazunori Miyaura Received Received
  PO-170 Impact of risk factors for long-term breast recurrence of APBI with interstitial HDR brachytherapy Jose Luis Guinot Received Received
  PO-171 Intraoperative Brachytherapy (HDR-IOBT) in advanced or recurrence gynecologic cancer. Ignacio Visus Received Received
  PO-172 Towards real-world quality cervical brachytherapy: how convergence met complexity, taxing capacity Fleur Huang Received Received
  PO-173 Needle localization in MRI-guided gynecological brachytherapy using a PETRA sequence Evangelia Kaza Received Received
  PO-174 Cervix cancer treated with PDR brachytherapy boost graeme dickie Received Received
  PO-175 Deformable registration for HDR Cervical case: Dose accumulation for multiple deformation techniques Vrinda Narayana Received Received
  PO-176 Clinical outcomes of cervical cancer with CT-based image-guided brachytherapy Wing Lok Chan Received Received
  PO-177 A new software for designing patient-specific caps for the Montreal split-ring applicator Borko Basaric Received Received
  PO-178 Feasibility and Outcomes for Cervical Cancer Patients Treated with Hybrid Brachytherapy Applicators Andrew Keller Received Received
  PO-179 Hypnosedation for endocavitary uterovaginal applications: a pilot study Manon KISSEL Received Received
  PO-181 Comparison of vaginal doses and toxicities between two brachytherapy applicators in Carcinoma Cervix Harjot Kaur Bajwa Received Received
  PO-182 Excellent Outcomes with CT-Based HDR Brachytherapy for Locally Advanced Cervical Cancer Jay Shiao Received Received
  PO-183 Intracavitary electronic brachytherapy (e-BT) for gynecological malignancies Gustavo R. Sarria Received Received
  PO-184 What do women say about their experiences of brachytherapy for cervical cancer? A qualitative study. Pauline HUMPHREY Received Received
  PO-186 Analysis of Outcomes and Cost Effectiveness of Inpatient vs. Outpatient Based Interstitial Vaginal Brachytherapy Soheila Azghadi Received Received
  PO-187 Vaginal dose reduction by changing the ovoidloading pattern in intracavitary brachytherapy of cervix Ramya Rangarajan Received Received
  PO-188 Are active dwells always necessary in the applicator ring in the brachytherapy of cervical cancer? Julia Vízkeleti Received Received
  PO-189 The second planning-CT in a two daily fractions implant can be omitted in cervical cancer IGABT Olga Engel Received Received
  PO-190 A single institution review of vaginal brachytherapy with customised moulds and interstitial needles Emily Flower Received Received
  PO-191 Plan evaluation of the interstitial contribution in brachytherapy for cancer cervix Anju Joy Received Received
  PO-192 Prototype testing the 3D-printed Montreal split-ring applicator (GYN) using biocompatible materials Yuji Kamio Received Received
  PO-193 Impact of Vaginal Reference Length on Organs at Risk doses in Carcinoma Cervix Brachytherapy Harjot Kaur Bajwa Received Received
  PO-194 Intracavitary brachytherapy for endometrial carcinoma: experience with Co-60 HDR brachytherapy. Jose Antonio Domínguez Rullán Received Received
  PO-195 Clinical outcome of intracavitary and interstitial brachytherapy in locally advanced cervical cancer Paramintra Chitmanee Received Received
  PO-197 Systemic Analysis of Vaginal Wall Dose Between Various Vaginal Brachytherapy Plans: Phantom case Robert Kim Received Received
  PO-198 Applicator-guided SBRT boost combined with intracavitary brachytherapy for advanced cervical cancer Camelia Constantinescu Received Received
  PO-199 HDR brachytherapy as a salvage therapy in head and neck cancers Mohamed Ait Erraisse Received Received
  PO-200 Comparison of catheter position planning algorithms for HDR prostate brachytherapy under uncertainty Marjolein van der Meer Received Received
  PO-201 A Miniature Robotic System for Interstitial Brachytherapy Needle Insertion Ivan Buzurovic Received Received
  PO-202 Commissioning of a Venezia applicator: discrepancies between expected and actual source positions Naiara Fuentemilla Received Received
  PO-203 Range of intra-fraction dose uncertainty in cervical cancer HDR brachytherapy. Victor Ferrándiz González Received Received
  PO-204 Towards an absolute dosimetry for 192-Ir high dose rate sources with micro-ionization chamber MIGUEL MARTINEZ ALBALADEJO Received Received
  PO-205 Deep learning for automated applicator reconstruction in high-dose-rate prostate brachytherapy Christopher Deufel Received Received
  PO-206 Evolution of brachytherapy cervix implants towards EMBRACE II recommendations Jose Chimeno Received Received
  PO-207 Radiation protection preparedness using LASAIR in case of malevolent use of brachytherapy sources Tomas Palmqvist Received Received
  PO-208 Do the results improve when using inverse planning multi-solution tool in HDR prostate BT? Naiara Fuentemilla Received Received
  PO-209 Practical considerations on the use of EM tracking technology for clinical HDR brachytherapy Marie Claude Lavallee Received Received
  PO-210 Status of HDR measurements at PTB Rolf Behrens Received Received
  PO-211 BrachyClip with I-125 seed Justine Dupere Received Received
  PO-212 Use of rectal spacing hydrogel significantly reduces rectal dose in prostate LDR brachytherapy Sheel Mehta Received Received
  PO-213 Development of equidistance marker to predict dwell position for MR-guided cervix brachytherapy Jeongho Kim Received Received
  PO-214 Investigation of obstructions in ring applicators during pulsed dose rate cervix brachytherapy Geetha Menon Received Received
  PO-215 A novel in-vivo 3D dosimetry device in GYN HDR brachytherapy using Micro Silica Bead TLDs Ramin Jaberi Received Received
  PO-216 Healthy tissue constraints for catheter position optimization in HDR prostate brachytherapy planning Marjolein van der Meer Received Received
  PO-218 Characterising a Papillon 50 electronic brachytherapy source using a plastic scintillation detector Peter Georgi Received Received
  PO-219 Analysis of the image quality of two different I-125 seed models using TRUS, MR and CT Horst Hermani Received Received
  PO-220 Determination of dose deposition from an Ocular Brachytherapy source: simulation data with TOPAS Iury Mergen Knoll Received Received
  PO-221 Statistical Analysis of Doses to Target & OAR during LDR Permanent Prostate Treatment for Monotherapy Patient Cohort Thomas Keogh Received Received
  PO-223 Ir-192 position measurement for pre-treatment QA using a fluorescent screen-based optical detector Wan Yan Lee Received Received
  PO-224 Dosimetric impact of a model based algorithm for skin cancer interventional radiotherapy Elisa Placidi Received Received
  PO-225 Automatic reporting of vaginal dose points for cervical cancer HDR-brachytherapy Jose Chimeno Received Received
  PO-226 3-D Printed modified S-Tube for treatment of cervical cancer with high dose rate brachytherapy Monique du Toit Received Received
  PO-227 Verification measurements for brachytherapy reference data Rachael Wilks Received Received
  PO-228 Inverse versus forward optimisation methods in brachytherapy of breast, cervix and prostate cancer Georgina Frhlich Received Received
  PO-229 Towards informed and digitized HDR brachytherapy QA: Quantitative analysis of GYN applicators Saad Aldelaijan Received Received
  PO-230 Subdomains of erectile and urinary function after ultrafocal HDR-brachytherapy for prostate cancer Max Peters Received Received
  PO-231 Using PSA Kinetics to Predict 5-yr Biochemical Failure in Intermediate-Risk Prostate Cancer Patients Thomas McMullan Received Received
  PO-233 A multi-protocol validation study of automated bi-objective planning for HDR prostate brachytherapy Anton Bouter Received Received
  PO-234 Feasibility in using a nomogram as an independent verification process in HDR prostate brachytherapy Paula Monasor Denia Received Received
  PO-235 HDR Prostate Brachytherapy Is 20 needles too many? Jennifer Wilson Received Received
  PO-236 HDR monotherapy for low and intermediate risk prostate cancer in one or two fractions VITALY BIRYUKOV Received Received
  PO-237 HDR monotherapy (2 fractions/13,5 Gy) in LR and favorable IR prostate cancer: analysis of toxicity. Silvia Rodriguez Villalba Received Received
  PO-238 LDR-HDR boost in patients with intermediate-risk prostate cancer. A single Institution experience. Silvia Rodríguez Villalba Received Received
  PO-239 20 Gy HDR brachytherapy as monotherapy for localized prostate cancer: Early outcomes Verónica González Vidal Received Received
  PO-241 Eligibility criteria according to EAU-ESTRO-SIOG guidelines for exclusive 125I brachytherapy for intermediate risk prostate adenocarcinoma patients: impact on relapse free survival. Sophie Robin Received Received
  PO-242 Treatment outcomes and toxicity in patients treated with LDR brachytherapy, single institution study Pavol Lukacko Received Received
  PO-243 HDR brachytherapy as monotherapy or a boost for high risk prostate cancer: 5 year single center data Sergey Novikov Received Received
  PO-244 HDR brachytherapy monotherapy with 2 x 13.5 Gy for localized prostate cancer: short term follow up Miranda Christianen Received Received
  PO-245 HDR Monotherapy/LDR-EBRT/HDR-EBRT in patients with favorable IR prostate cancer: Long term results. Silvia Rodríguez Villalba Received Received
  PO-247 Prostate HDR boost: urethra V110 constraints correspond to low adverse effects Ileana Iftimia Received Received
  PO-249 Comparison of two different Low Dose Rate (LDR) Brachytherapy techniques - a retrospective analysis Carlos Villalon Arias Received Received
  PO-250 MRI-Guided Robotic Prostate Biopsy and Brachytherapy: Update from the EU-funded CoBra Project sarah Wilby Received Received
  PO-251 Clinical outcomes of radiation therapy for high-risk prostate cancer. Ksenia Makarova Received Received
  PO-252 Technical Evaluation of 3D Printed Disposable Seed Loader for LDR Cs-131 Prostate Brachytherapy Marjan Khosravi Received Received
  PO-253 Real-time intraoperative-planning reduces toxicity in LDR-brachytherapy-boost in prostate cancer Marta Barrado Received Received
  PO-254 A systematic review of intraluminal HDR brachytherapy in the management of cholangiocarcinoma Amandeep Taggar Received Received
  PO-255 CT-guided high-dose interstitial brachytherapy vs. SBRT in hepatocellular carcinoma Franziska Walter Received Received
  PO-256 Episcleral Brachytherapy for Uveal Melanoma - Reference Center experience Bruno Moura Fernandes Received Received
  PO-257 Perioperative Radiation with/without High Dose Rate Brachytherapy for High-risk Soft Tissue Sarcoma James Assif Received Received
  PO-258 How to design, fabricate, and validate a customized COMs-style eye plaque Christopher Deufel Received Received
  PO-259 Single-fraction adjuvant electronic brachytherapy after resection of conjunctival carcinoma Gustavo R. Sarria Received Received
  PO-260 INTERBOARD: a dedicated tumor board to deal with personalized medicine in interventional oncology. Calogero Casŕ Received Received
  PO-261 Adjuvant HDR contact brachytherapy for localized penile cancer: long-term toxicities and outcomes Paula Pircalab Received Received
  PO-262 Brachytherapy for paediatric pelvic tumours sole local therapy modality and combined with surgery Jennifer Chard Received Received
  PO-263 A Matlab toolkit for Ru-106 eye plaque QA, dose calculation, reference table and report generation Laurence Delombaerde Received Received
  PO-264 orbital mold brachytherapy for recurrent orbital mesenchymal sarcoma: a contemporary approach Eugene Yap Received Received
  PO-265 Intraluminal HDR brachytherapy as a component of induction chemoradiotherapy for esophageal cancer Sergey Novikov Received Received
  PO-266 Dosimetric comparison of brachytherapy and tomotherapy for a large SCC on the scalp Regina Gonzalez Vaz Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Cristina Miralles
Hours: Mon-Fri 8:30-15:00
12:56
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

World Congress of Brachytherapy 2021

 

May 06-08, 2021 Online Congress
FAQs
Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 05/04/2021 TO 06/05/2022
Poster
Gallery
Upload
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
                  
Download Template




PosterSessionOnline
Logo Draft
 
Logo Cert